RBC Europe’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | $219K | Hold |
3,547
| – | – | 0.01% | 197 |
|
|
2022
Q1 | $211K | Sell |
3,547
-218
| -6% | -$13K | 0.01% | 216 |
|
|
2021
Q4 | $273K | Buy |
3,765
+1,187
| +46% | +$86.1K | 0.01% | 201 |
|
|
2021
Q3 | $180K | Sell |
2,578
-60
| -2% | -$4.19K | 0.01% | 317 |
|
|
2021
Q2 | $182K | Sell |
2,638
-40
| -1% | -$2.75K | 0.01% | 328 |
|
|
2021
Q1 | $173K | Sell |
2,678
-2,375
| -47% | -$153K | 0.01% | 312 |
|
|
2020
Q4 | $294K | Sell |
5,053
-80
| -2% | -$4.66K | 0.02% | 230 |
|
|
2020
Q3 | $324K | Sell |
5,133
-594
| -10% | -$37.5K | 0.02% | 205 |
|
|
2020
Q2 | $441K | Buy |
5,727
+140
| +3% | +$10.8K | 0.03% | 173 |
|
|
2020
Q1 | $418K | Buy |
5,587
+1,280
| +30% | +$95.7K | 0.04% | 147 |
|
|
2019
Q4 | $280K | Sell |
4,307
-272
| -6% | -$17.7K | 0.02% | 204 |
|
|
2019
Q3 | $290K | Buy |
4,579
+76
| +2% | +$4.82K | 0.03% | 204 |
|
|
2019
Q2 | $304K | Sell |
4,503
-375
| -8% | -$25.3K | 0.03% | 208 |
|
|
2019
Q1 | $317K | Hold |
4,878
| – | – | 0.04% | 195 |
|
|
2018
Q4 | $305K | Hold |
4,878
| – | – | 0.04% | 182 |
|
|
2018
Q3 | $377K | Sell |
4,878
-6,766
| -58% | -$522K | 0.04% | 185 |
|
|
2018
Q2 | $825K | Sell |
11,644
-565
| -5% | -$40K | 0.1% | 127 |
|
|
2018
Q1 | $920K | Sell |
12,209
-200
| -2% | -$15.1K | 0.11% | 114 |
|
|
2017
Q4 | $889K | Hold |
12,409
| – | – | 0.11% | 115 |
|
|
2017
Q3 | $1.01M | Buy |
+12,409
| New | +$1.01M | 0.13% | 104 |
|